Do systemic cancer treatments affect cognitive function?

被引：13

作者：

Ahles, TA ^{[1
]}

机构：

[1] Dartmouth Hitchcock Med Ctr, Dept Psychiat, Lebanon, NH 03766 USA

[2] Dartmouth Hitchcock Med Ctr, Norris Cotton Canc Ctr, Lebanon, NH 03766 USA

来源：

LANCET ONCOLOGY | 2004年 / 5卷 / 05期

关键词：

D O I：

10.1016/S1470-2045(04)01463-9

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：270 / 271

页数：2

共 7 条

[1] The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy [J].

Ahles, TA ;

Saykin, AJ ;

Noll, WW ;

Furstenberg, CT ;

Guerin, S ;

Cole, B ;

Mott, LA .

PSYCHO-ONCOLOGY, 2003, 12 (06) :612-619

[2] Neuropsychological effects of treatments for adults with cancer: A meta-analysis and review of the literature [J].

Anderson-Hanley, C ;

Sherman, ML ;

Riggs, R ;

Agocha, VB ;

Compas, BE .

JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY, 2003, 9 (07) :967-982

[3] Low neuropsychologic performance among adult cancer survivors treated with chemotherapy [J].

Robert J. Ferguson ;

Tim A. Ahles .

Current Neurology and Neuroscience Reports, 2003, 3 (3) :215-222

[4] What is the effect of systemic anticancer treatment on cognitive function? [J].

Minisini, A ;

Atalay, G ;

Bottomley, A ;

Puglisi, F ;

Piccart, M ;

Biganzoli, L .

LANCET ONCOLOGY, 2004, 5 (05) :273-282

[5] The apolipoprotein E gene, attention, and brain function [J].

Parasuraman, R ;

Greenwood, PM ;

Sunderland, T .

NEUROPSYCHOLOGY, 2002, 16 (02) :254-274

[6] The impact of adjuvant therapy for breast cancer on cognitive function: Current evidence and directions for research [J].

Rugo, HS ;

Ahles, T .

SEMINARS IN ONCOLOGY, 2003, 30 (06) :749-762

[7]

Saykin Andrew J, 2003, Semin Clin Neuropsychiatry, V8, P201

← 1 →